Loading…
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
Trial Registration: Clinical Trials.gov identifer: NCT03345342
Saved in:
| Published in: | International Journal of Neuropsychopharmacology 2022, Vol.25 (3), p.238 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Report |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | |
| container_issue | 3 |
| container_start_page | 238 |
| container_title | International Journal of Neuropsychopharmacology |
| container_volume | 25 |
| creator | Najarian, Dean Sanga, Panna Wang, Steven Lim, Pilar Singh, Arun Robertson, Mary Jane Cohen, Kristin Schotte, Alain Milz, Ruth Venkatasubramanian, Raja T'Jollyn, Huybrecht Walling, David P Galderisi, Silvana Gopal, Srihari |
| description | Trial Registration: Clinical Trials.gov identifer: NCT03345342 |
| doi_str_mv | 10.1093/ijnp/pyab071 |
| format | report |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A711329676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A711329676</galeid><sourcerecordid>A711329676</sourcerecordid><originalsourceid>FETCH-gale_infotracmisc_A7113296763</originalsourceid><addsrcrecordid>eNqNTstKw0AUnYWC9bHzAy64bWymSRO6jFVRsCJWdFmmk9vkhuROmJks0p_yF51CP8DV4bw4R4hbGd_LeJnMqOF-1o9qF-fyTExkmslIpov8Qlw618TxPF0k2UT8FvCpuDQdHbCcwqMZdi1GDy1xYOuh9aSRPdopvBsm3qMlY8mPsPFDOcLKdL2yxBV8qJb64JaG8Ug68sojZNHasK_hG60bHPgaITlJb4arqND-2H7lBrVXYRuIQ91TWHXwQyG30TUdTF9bZFLX4nyvWoc3J7wSd89PX6uXqFItbsNB463SHTm9LXIpk_kyy7Pkf6k_Psll_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia</title><source>OUP_牛津大学出版社OA刊</source><source>PubMed Central</source><creator>Najarian, Dean ; Sanga, Panna ; Wang, Steven ; Lim, Pilar ; Singh, Arun ; Robertson, Mary Jane ; Cohen, Kristin ; Schotte, Alain ; Milz, Ruth ; Venkatasubramanian, Raja ; T'Jollyn, Huybrecht ; Walling, David P ; Galderisi, Silvana ; Gopal, Srihari</creator><creatorcontrib>Najarian, Dean ; Sanga, Panna ; Wang, Steven ; Lim, Pilar ; Singh, Arun ; Robertson, Mary Jane ; Cohen, Kristin ; Schotte, Alain ; Milz, Ruth ; Venkatasubramanian, Raja ; T'Jollyn, Huybrecht ; Walling, David P ; Galderisi, Silvana ; Gopal, Srihari</creatorcontrib><description>Trial Registration: Clinical Trials.gov identifer: NCT03345342</description><identifier>ISSN: 1461-1457</identifier><identifier>DOI: 10.1093/ijnp/pyab071</identifier><language>eng</language><publisher>Oxford University Press</publisher><subject>Dosage and administration ; Drug therapy ; Drugs ; Patient outcomes ; Schizophrenia</subject><ispartof>International Journal of Neuropsychopharmacology, 2022, Vol.25 (3), p.238</ispartof><rights>COPYRIGHT 2022 Oxford University Press</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27902</link.rule.ids></links><search><creatorcontrib>Najarian, Dean</creatorcontrib><creatorcontrib>Sanga, Panna</creatorcontrib><creatorcontrib>Wang, Steven</creatorcontrib><creatorcontrib>Lim, Pilar</creatorcontrib><creatorcontrib>Singh, Arun</creatorcontrib><creatorcontrib>Robertson, Mary Jane</creatorcontrib><creatorcontrib>Cohen, Kristin</creatorcontrib><creatorcontrib>Schotte, Alain</creatorcontrib><creatorcontrib>Milz, Ruth</creatorcontrib><creatorcontrib>Venkatasubramanian, Raja</creatorcontrib><creatorcontrib>T'Jollyn, Huybrecht</creatorcontrib><creatorcontrib>Walling, David P</creatorcontrib><creatorcontrib>Galderisi, Silvana</creatorcontrib><creatorcontrib>Gopal, Srihari</creatorcontrib><title>A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia</title><title>International Journal of Neuropsychopharmacology</title><description>Trial Registration: Clinical Trials.gov identifer: NCT03345342</description><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Patient outcomes</subject><subject>Schizophrenia</subject><issn>1461-1457</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqNTstKw0AUnYWC9bHzAy64bWymSRO6jFVRsCJWdFmmk9vkhuROmJks0p_yF51CP8DV4bw4R4hbGd_LeJnMqOF-1o9qF-fyTExkmslIpov8Qlw618TxPF0k2UT8FvCpuDQdHbCcwqMZdi1GDy1xYOuh9aSRPdopvBsm3qMlY8mPsPFDOcLKdL2yxBV8qJb64JaG8Ug68sojZNHasK_hG60bHPgaITlJb4arqND-2H7lBrVXYRuIQ91TWHXwQyG30TUdTF9bZFLX4nyvWoc3J7wSd89PX6uXqFItbsNB463SHTm9LXIpk_kyy7Pkf6k_Psll_A</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Najarian, Dean</creator><creator>Sanga, Panna</creator><creator>Wang, Steven</creator><creator>Lim, Pilar</creator><creator>Singh, Arun</creator><creator>Robertson, Mary Jane</creator><creator>Cohen, Kristin</creator><creator>Schotte, Alain</creator><creator>Milz, Ruth</creator><creator>Venkatasubramanian, Raja</creator><creator>T'Jollyn, Huybrecht</creator><creator>Walling, David P</creator><creator>Galderisi, Silvana</creator><creator>Gopal, Srihari</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20220301</creationdate><title>A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia</title><author>Najarian, Dean ; Sanga, Panna ; Wang, Steven ; Lim, Pilar ; Singh, Arun ; Robertson, Mary Jane ; Cohen, Kristin ; Schotte, Alain ; Milz, Ruth ; Venkatasubramanian, Raja ; T'Jollyn, Huybrecht ; Walling, David P ; Galderisi, Silvana ; Gopal, Srihari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracmisc_A7113296763</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Patient outcomes</topic><topic>Schizophrenia</topic><toplevel>online_resources</toplevel><creatorcontrib>Najarian, Dean</creatorcontrib><creatorcontrib>Sanga, Panna</creatorcontrib><creatorcontrib>Wang, Steven</creatorcontrib><creatorcontrib>Lim, Pilar</creatorcontrib><creatorcontrib>Singh, Arun</creatorcontrib><creatorcontrib>Robertson, Mary Jane</creatorcontrib><creatorcontrib>Cohen, Kristin</creatorcontrib><creatorcontrib>Schotte, Alain</creatorcontrib><creatorcontrib>Milz, Ruth</creatorcontrib><creatorcontrib>Venkatasubramanian, Raja</creatorcontrib><creatorcontrib>T'Jollyn, Huybrecht</creatorcontrib><creatorcontrib>Walling, David P</creatorcontrib><creatorcontrib>Galderisi, Silvana</creatorcontrib><creatorcontrib>Gopal, Srihari</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Najarian, Dean</au><au>Sanga, Panna</au><au>Wang, Steven</au><au>Lim, Pilar</au><au>Singh, Arun</au><au>Robertson, Mary Jane</au><au>Cohen, Kristin</au><au>Schotte, Alain</au><au>Milz, Ruth</au><au>Venkatasubramanian, Raja</au><au>T'Jollyn, Huybrecht</au><au>Walling, David P</au><au>Galderisi, Silvana</au><au>Gopal, Srihari</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia</atitle><jtitle>International Journal of Neuropsychopharmacology</jtitle><date>2022-03-01</date><risdate>2022</risdate><volume>25</volume><issue>3</issue><spage>238</spage><pages>238-</pages><issn>1461-1457</issn><abstract>Trial Registration: Clinical Trials.gov identifer: NCT03345342</abstract><pub>Oxford University Press</pub><doi>10.1093/ijnp/pyab071</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1461-1457 |
| ispartof | International Journal of Neuropsychopharmacology, 2022, Vol.25 (3), p.238 |
| issn | 1461-1457 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A711329676 |
| source | OUP_牛津大学出版社OA刊; PubMed Central |
| subjects | Dosage and administration Drug therapy Drugs Patient outcomes Schizophrenia |
| title | A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T02%3A11%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=A%20Randomized,%20Double-Blind,%20Multicenter,%20Noninferiority%20Study%20Comparing%20Paliperidone%20Palmitate%206-Month%20Versus%20the%203-Month%20Long-Acting%20Injectable%20in%20Patients%20With%20Schizophrenia&rft.jtitle=International%20Journal%20of%20Neuropsychopharmacology&rft.au=Najarian,%20Dean&rft.date=2022-03-01&rft.volume=25&rft.issue=3&rft.spage=238&rft.pages=238-&rft.issn=1461-1457&rft_id=info:doi/10.1093/ijnp/pyab071&rft_dat=%3Cgale%3EA711329676%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_infotracmisc_A7113296763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A711329676&rfr_iscdi=true |